CSF3R and atypical chronic myeloid leukemia, BCR-ABL1 negative: Recently, acquired CSF3R mutations (in particular the CSF3R T618I mutation) were described in a majority of patients diagnosed with CNL or atypical chronic myeloid leukemia (aCML) [2, 7].